Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Adenovirus multiple sclerosis:

Search results

Items: 1 to 20 of 57

1.

HMGB1 silencing in macrophages prevented their functional skewing and ameliorated EAM development: Nuclear HMGB1 may be a checkpoint molecule of macrophage reprogramming.

Jiang Y, Chen R, Shao X, Ji X, Lu H, Zhou S, Zong G, Xu H, Su Z.

Int Immunopharmacol. 2018 Mar;56:277-284. doi: 10.1016/j.intimp.2018.01.013. Epub 2018 Feb 2.

PMID:
29414662
2.

Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease.

Moghadam S, Erfanmanesh M, Esmaeilzadeh A.

Med Hypotheses. 2017 Nov;109:102-105. doi: 10.1016/j.mehy.2017.09.017. Epub 2017 Sep 22.

PMID:
29150266
3.

Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?

Brown N, Song L, Kollu NR, Hirsch ML.

Hum Gene Ther. 2017 Jun;28(6):450-463. doi: 10.1089/hum.2017.038. Review.

4.

Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.

Garanina EE, Mukhamedshina YO, Salafutdinov II, Kiyasov AP, Lima LM, Reis HJ, Palotás A, Islamov RR, Rizvanov AA.

Spinal Cord. 2016 Jun;54(6):423-30. doi: 10.1038/sc.2015.162. Epub 2015 Oct 6.

PMID:
26439843
5.

[Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].

Ismailov ShM, Barykova IuA, Shmarov MM, Tarantul VZ, Barskov IV, Kucherianu VG, Brylev LV, Logunov DIu, Tutykhina IL, Bocharov EV, Zakharova MN, Naroditskiĭ BS, Illarioshkin SN.

Genetika. 2014 May;50(5):591-601. Russian.

PMID:
25715475
6.

Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood-brain barrier integrity.

Murta V, Farías MI, Pitossi FJ, Ferrari CC.

J Neuroimmunol. 2015 Jan 15;278:30-43. doi: 10.1016/j.jneuroim.2014.11.023. Epub 2014 Nov 28.

PMID:
25595250
7.

Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?

Pender MP, Khanna R.

Immunotherapy. 2014;6(6):659-61. doi: 10.2217/imt.14.43. No abstract available.

8.

Regulation of autophagy by stress-responsive transcription factors.

Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G.

Semin Cancer Biol. 2013 Oct;23(5):310-22. doi: 10.1016/j.semcancer.2013.05.008. Epub 2013 May 30. Review.

PMID:
23726895
9.

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.

Serres S, Bristow C, de Pablos RM, Merkler D, Soto MS, Sibson NR, Anthony DC.

J Cereb Blood Flow Metab. 2013 May;33(5):744-53. doi: 10.1038/jcbfm.2013.12. Epub 2013 Feb 20.

10.

MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Walls GV, Lemos MC, Javid M, Bazan-Peregrino M, Jeyabalan J, Reed AA, Harding B, Tyler DJ, Stuckey DJ, Piret S, Christie PT, Ansorge O, Clarke K, Seymour L, Thakker RV.

Cancer Res. 2012 Oct 1;72(19):5060-8. doi: 10.1158/0008-5472.CAN-12-1821. Epub 2012 Aug 21.

11.

Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Tarassishin L, Loudig O, Bauman A, Shafit-Zagardo B, Suh HS, Lee SC.

Glia. 2011 Dec;59(12):1911-22. doi: 10.1002/glia.21233.

12.
13.

Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.

Oikonen M, Laaksonen M, Aalto V, Ilonen J, Salonen R, Erälinna JP, Panelius M, Salmi A.

Mult Scler. 2011 Jun;17(6):672-80. doi: 10.1177/1352458510394397. Epub 2011 Jan 6.

PMID:
21212088
14.

The murine gammaherpesvirus-68 chemokine-binding protein M3 inhibits experimental autoimmune encephalomyelitis.

Millward JM, Holst PJ, Høgh-Petersen M, Thomsen AR, Christensen JP, Owens T.

J Neuroimmunol. 2010 Jul 27;224(1-2):45-50. doi: 10.1016/j.jneuroim.2010.05.005.

PMID:
20537410
15.

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.

Hu Y, Turner MJ, Shields J, Gale MS, Hutto E, Roberts BL, Siders WM, Kaplan JM.

Immunology. 2009 Oct;128(2):260-70. doi: 10.1111/j.1365-2567.2009.03115.x.

16.

Molecular and biotechnological advances in milk proteins in relation to human health.

Kanwar JR, Kanwar RK, Sun X, Punj V, Matta H, Morley SM, Parratt A, Puri M, Sehgal R.

Curr Protein Pept Sci. 2009 Aug;10(4):308-38. Review.

PMID:
19689355
17.

Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation.

Lu JQ, Storek J, Metz L, Yong VW, Stevens AM, Nash RA, Joseph JT.

Arch Neurol. 2009 Jan;66(1):116-20. doi: 10.1001/archneurol.2008.522.

PMID:
19139309
18.

Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark Agouti (DA) rats.

Zhu CS, Hu XQ, Xiong ZJ, Lu ZQ, Zhou GY, Wang DJ.

Life Sci. 2008 Sep 12;83(11-12):404-12. doi: 10.1016/j.lfs.2008.07.009. Epub 2008 Jul 30.

PMID:
18721816
19.

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.

Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A, Comi G, Pluchino S, Mavilio F, Martino G, Furlan R.

Gene Ther. 2008 Apr;15(7):504-15. doi: 10.1038/gt.2008.10. Epub 2008 Jan 31.

PMID:
18239607
20.

Beta-interferon protects multiple sclerosis patients against enhanced susceptibility to infections caused by poor air quality.

Oikonen MK, Erälinna JP.

Neuroepidemiology. 2008;30(1):13-9. doi: 10.1159/000113301. Epub 2008 Jan 17.

PMID:
18204292

Supplemental Content

Loading ...
Support Center